PMV Pharmaceuticals (PMVP)
(Real Time Quote from BATS)
$1.50 USD
0.00 (0.00%)
Updated Oct 2, 2024 10:42 AM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for PMV Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -68.96 | -73.32 | -57.85 | -34.44 | -25.35 |
Depreciation/Amortization & Depletion | -4.13 | -0.31 | 0.86 | 0.47 | 0.45 |
Net Change from Assets/Liabilities | 5.43 | -0.57 | 4.12 | -0.85 | 1.92 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 12.01 | 10.44 | 6.30 | 2.08 | 0.92 |
Net Cash From Operating Activities | -55.66 | -63.76 | -46.57 | -32.74 | -22.07 |
Property & Equipment | -0.96 | -7.98 | -1.35 | -0.15 | -0.11 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -49.58 | 6.62 | -142.24 | 28.06 | 3.34 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -50.55 | -1.37 | -143.58 | 27.91 | 3.23 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 35.58 | 0.96 | 2.02 | 292.97 | 61.81 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 35.58 | 0.96 | 2.02 | 292.97 | 61.81 |
Effect of Exchange Rate Changes | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -70.59 | -64.17 | -188.13 | 288.14 | 42.97 |
Cash at Beginning of Period | 109.12 | 173.29 | 361.42 | 73.28 | 30.31 |
Cash at End of Period | 38.53 | 109.12 | 173.29 | 361.42 | 73.28 |
Diluted Net EPS | -1.44 | -1.61 | -1.28 | -2.40 | NA |
Fiscal Year End for PMV Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -16.48 | -15.27 | -68.96 | -53.20 | -36.56 |
Depreciation/Amortization & Depletion | -2.27 | -1.27 | -4.13 | -2.61 | -1.13 |
Net Change from Assets/Liabilities | -4.22 | -2.17 | 5.43 | 3.12 | 3.88 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 5.19 | 2.53 | 12.01 | 9.13 | 5.90 |
Net Cash From Operating Activities | -17.78 | -16.18 | -55.66 | -43.57 | -27.91 |
Property & Equipment | -0.60 | -0.59 | -0.96 | -0.77 | -0.72 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 29.09 | 26.76 | -49.58 | -47.19 | -13.60 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 28.49 | 26.17 | -50.55 | -47.96 | -14.32 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.14 | 0.00 | 35.58 | 35.29 | 2.14 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.14 | 0.00 | 35.58 | 35.29 | 2.14 |
Effect of Exchange Rate Changes | -0.03 | -0.03 | 0.03 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 10.82 | 9.95 | -70.59 | -56.24 | -40.09 |
Cash at Beginning of Period | 38.53 | 38.53 | 109.12 | 109.12 | 109.12 |
Cash at End of Period | 49.35 | 48.48 | 38.53 | 52.88 | 69.03 |
Diluted Net EPS | -0.02 | -0.30 | -0.30 | -0.34 | -0.38 |